Clinical Trials Browser

OTHER × Prostatic Neoplasms × Sunitinib × Clear all

NCT00329043 2025-12-26

Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT01254864 2025-01-27

Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies

Phase 2 Completed

190 enrolled 9 charts

Prostatic Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00879619 2017-02-01

Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients

Phase 1/2 Terminated

4 enrolled 3 charts

Prostatic Neoplasms

NCT01803503 2016-06-22

Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors

Phase 2 Unknown

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Stomach Neoplasms

NCT00734851 2015-12-23

Multimodality Phase II Study in Prostate Cancer

Phase 2 Terminated

36 enrolled 8 charts

Prostatic Neoplasms

NCT00631527 2015-01-29

Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT00672594 2014-08-04

Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy

Phase 2 Completed

30 enrolled 7 charts

Prostatic Neoplasms

NCT00748358 2013-09-18

PROSUT

Phase 2 Completed

Neoplasms, Hormone-Dependent, Prostatic Neoplasms

NCT00299741 2012-12-19

Study of SU11248 in Men With Advanced Prostate Cancer

Phase 2 Completed

36 enrolled 8 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT00790595 2012-07-31

Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy

Phase 1 Completed

Prostatic Neoplasms

NCT00550810 2011-12-07

SMART

Phase 2 Unknown

Prostatic Neoplasms